Indian Immunologicals launches VAXTAR 5
IIL will manufacture the vaccine in its state-of-the-art vaccine manufacturing facility in Hyderabad
Author
New drug may stop cancer-causing gene in its tracks
Researchers at the Michigan State University in the US showed that the drug, I-BET-762, is showing signs of significantly delaying…
Lupin launches generic Lodosyn tabs in the US
The drug is used for the treatment of idiopathic Parkinson’s disease
Aptar Pharma to showcase next generation of integrated connected devices at RDD 2018 Arizona
As part of the Platinum Sponsor Seminars at RDD 2018, Aptar Pharma experts will present a 40-minute talk on the most recent FDA…
Cipla launches authorised generic of Aloxi in the US
The drug is indicated for prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of…
DRL launches palonosetron hydrochloride injection in the US
The injection is available in a strength of 0.25 mg/5 mL (free base) in a single-dose vial packaged in a carton containing one…
Syngene International signs R&D agreement with GSK
Syngene will set-up a customised discovery research laboratory to support projects across several therapeutic areas
Tata Chemicals launches Medikarb
Medikarb is India’s first branded pharmaceutical grade sodium bicarbonate
IPSCON 2017 held in Mumbai
The three-day conference was enriched with various scientific sessions that extensively covered vital current issues